Android app on Google Play

Pharmacyclics (PCYC) Get Boost Following New Executive Addition

August 15, 2012 10:18 AM EDT Send to a Friend
Pharmacyclics, Inc. (Nasdaq: PCYC) is getting a boost Wednesday following a positive management change announced late Tuesday night.

The Company added Josh Brumm from ZELTIQ Aesthetics, Inc (Nasdaq: ZLTQ) as its new EVP of Finance. Pharmacyclics said Brumm will have global responsibility for corporate finance, accounting, investor relations and IT.

Shares of Pharmacyclics are up nearly 4 percent in morning trade.




You May Also Be Interested In


Related Categories

Insiders' Blog, Management Changes

Add Your Comment